Royal Bank of Canada’s Invesco NASDAQ Biotechnology ETF IBBQ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$38K Hold
1,306
﹤0.01% 5621
2025
Q4
$37K Buy
+1,306
New +$35.6K ﹤0.01% 5708
2024
Q4
Sell
-369
Closed -$9K 7046
2024
Q3
$9K Sell
369
-12,026
-97% -$287K ﹤0.01% 6360
2024
Q2
$282K Buy
12,395
+8,638
+230% +$189K ﹤0.01% 4474
2024
Q1
$83K Buy
3,757
+3,316
+752% +$73.5K ﹤0.01% 5285
2023
Q4
$10K Sell
441
-1,883
-81% -$37.1K ﹤0.01% 6494
2023
Q3
$46K Sell
2,324
-404
-15% -$8.24K ﹤0.01% 5826
2023
Q2
$56K Sell
2,728
-596
-18% -$12.5K ﹤0.01% 5721
2023
Q1
$69K Buy
3,324
+1,438
+76% +$30.1K ﹤0.01% 5443
2022
Q4
$40K Buy
1,886
+1,618
+604% +$33.5K ﹤0.01% 6013
2022
Q3
$5K Buy
+268
New +$5.32K ﹤0.01% 6730
2022
Q2
Sell
-92,687
Closed -$1.94M 7519
2022
Q1
$1.94M Buy
+92,687
New +$1.92M ﹤0.01% 3082

Other funds holding IBBQ

Royal Bank of Canada's IBBQ Position: Q1 2026 in Review

Royal Bank of Canada held its Invesco NASDAQ Biotechnology ETF (IBBQ) position steady in Q1 2026 at 1,306 shares worth $38K. The position accounts for ﹤0.01% of the portfolio, ranked #5621.

Royal Bank of Canada first reported a position in IBBQ in Q1 2022 and has held it in 12 quarters since. The position peaked at $1.94M in Q1 2022. 40 funds tracked by Wall St. Rank hold IBBQ as of Q1 2026.

  • Royal Bank of Canada held 1,306 shares of Invesco NASDAQ Biotechnology ETF worth $38K as of Q1 2026.
  • Royal Bank of Canada left its Invesco NASDAQ Biotechnology ETF share count unchanged in Q1 2026.
  • Invesco NASDAQ Biotechnology ETF made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #5621 holding.
  • Royal Bank of Canada first reported a position in Invesco NASDAQ Biotechnology ETF in Q1 2022 and has held it in 12 quarters since.
  • Royal Bank of Canada's Invesco NASDAQ Biotechnology ETF position peaked at $1.94M in Q1 2022.
  • 40 funds tracked by Wall St. Rank held Invesco NASDAQ Biotechnology ETF as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.